Pharmaceuticals, Biotechnology and Life Sciences
Centogene said Tuesday it will expand its testing efforts for the novel coronavirus, or COVID-19, from previously testing in Germany’s Mecklenburg-Western Pomerania region, to now offering its extensively validated SARS-CoV-2 RT-PCR testing to the rest of the world.
Shionogis’ Fetcroja (cefiderocol) in the end of April 2020 received European Commission (EC) marketing authorisation for the treatment of infections due to aerobic Gram-negative bacteria in adults with limited treatment options.
Certain people need to take additional energy in the form of specific supplements, but they are not a substitute for a balanced healthy diet.
Mylan and Biocon have launched Fulphila, a biosimilar to Neulasta (pegfilgrastim), as it was approved by Health Canada to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-neoplastic drugs.
Incyte last week named new Canada Biosciencess head, announcing establishing key development and commercialization capabilities in preparation for potential launches of multiple products in the near future.
Sanofi believes its brain-penetrant BTK inhibitor shows promise for reducing both neuroinflammation and neurodegeneration, markers of disability progression in people living with MS.
Roche got approval from US Food and Drug Administration (FDA) for the cobas HPV test for use on the fully automated, high-throughput cobas 6800/8800 Systems which identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples.
4basebio AG is working on developing a faster and more sensitive test for SARS-CoV-2 infection with the funds from the Carlos III Health Institute (Instituto de Salud Carlos III) that belongs to the Spanish Ministry of Science and Innovation.
Actinium expects to raise $27.5 million to invest in its Sierra phase 3 trial, as well as other programs with…
PrecisionLife is extending its relationships with some of the largest COVID-19 collaborative research projects as it offers free use of its analytics platform and support from its data and biomedical science teams in the fight against COVID19 coronavirus.